Compound details
Glyceollin I
| Compound ID | CDAMM01452 |
|---|---|
| Common name | Glyceollin I | IUPAC name | 17,17-dimethyl-3,12,18-trioxapentacyclo[11.8.0.02,10.04,9.014,19]henicosa-1(13),4(9),5,7,14(19),15,20-heptaene-6,10-diol |
| Molecular formula | C20H18O5 |
| Retention time | 11.14 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 339.127 | Theoretical mz | 339.122 |
| Error | 13.93 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.3331 |
| Inchi key | YIFYYPKWOQSCRI-UHFFFAOYNA-N |
|---|---|
| Smiles | OC1=CC=C2C(OC3C4=CC=C5OC(C=CC5=C4OCC23O)(C)C)=C1 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Isoflavonoids |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T60366 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | P11926 | ODC1 |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |